Evidence map›Paper›PMID 34449711›Full record

ArticlePharmacy (Basel, Switzerland)2021

Smoking Cessation at the Community Pharmacy: Determinants of Success from a Real-Life Practice.

Mónica Condinho, Isabel Ramalhinho, Carlos Sinogas

Open access · goldAbstract read
In one paragraph

Article in Pharmacy (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Role of Portuguese community pharmacy and pharmacists in self-care.Exploratory research in clinical and social pharmacy · 2023
    Article
  10. Smoking Cessation Services by Community Pharmacists: Real-World Practice in Thailand.International journal of environmental research and public health · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Mónica CondinhoAcF-Acompanhamento Farmacoterapêutico Lda, 7490-324 Pavia, Portugal.ORCID 0000-0002-4518-6764
Isabel RamalhinhoFaculdade de Ciências e Tecnologia, Universidade do Algarve, 8005-139 Faro, Portugal.
Carlos SinogasAcF-Acompanhamento Farmacoterapêutico Lda, 7490-324 Pavia, Portugal.ORCID 0000-0002-7161-1736
University of Algarve · PTUniversity of Évora · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objectives of this study are to report the contribution of pharmacists to smoking cessation and study the determinants of smoking cessation success in eight pharmacies in Portugal (south) between 2009 and 2019. A real-life study was conducted with a sample of smokers who participated in pharmacist consultations. The sample included 135 smokers (average age of 47.9 ± 1.21 years), 79 (58.5%) of whom were male. In parallel with the motivation and behavioral approach, 116 (85.9%) smokers received pharmacological therapies: 108 (80.0%) were treated with nicotine replacement products and eight (5.9%) with non-nicotine medications. The interventions resulted in 70 (51.9%) smokers complying with the quit day, of whom 59 (43.7%) were smoking-abstinent at the end of the first month. Success rates were reduced to 32.6%, 28.1%, and 20.7% at the end of the 3rd, 6th, and 12th months, respectively. Smoking cessation was more successful for the participants receiving pharmacological therapies (Fisher's exact test,

Indexed as

community pharmacydeterminantspharmacistPortugalsmoking cessation

Identifiers

PMID34449711
PMCPMC8396305
OpenAlexW3194928674

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.